DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-8.18%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$3.15B
AUM Growth
+$3.15B
(+0.62%)
Cap. Flow
+$240M
Cap. Flow
% of AUM
7.63%
Top 10 Holdings %
Top 10 Hldgs %
42.21%
Holding
105
New
27
Increased
25
Reduced
19
Closed
17
Top Buys
| 1 |
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
|
$103M |
| 2 |
Viatris
VTRS
|
$59.6M |
| 3 |
Schrodinger
SDGR
|
$58M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
$54.6M |
| 5 |
Pacira BioSciences
PCRX
|
$54.6M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$92.3M |
| 2 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$71.3M |
| 3 |
Tandem Diabetes Care
TNDM
|
$61M |
| 4 |
Humana
HUM
|
$30.1M |
| 5 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$29.6M |
Sector Composition
| 1 | Healthcare | 71.83% |
| 2 | Technology | 0.07% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amicus Therapeutics
FOLD
$2.42B
| $30.1M | 0.95% |
+3,253,960
| New | +$30.1M |
|
|
CNST
27
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $30M | 0.95% |
954,100
+404,100
| +73% | +$12.7M |
|
|
BPMC
28
DELISTED
Blueprint Medicines
BPMC
| $26.8M | 0.85% |
457,968
-106,946
| -19% | -$6.25M |
|
|
29
Tandem Diabetes Care
TNDM
$834M
| $26.6M | 0.84% |
412,867
-948,478
| -70% | -$61M |
|
|
RETA
30
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $26.5M | 0.84% |
183,865
+83,865
| +84% | +$12.1M |
|
|
DCPH
31
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $24.3M | 0.77% |
589,485
+281,485
| +91% | +$11.6M |
|
32
McKesson
MCK
$85.9B
| $23.7M | 0.75% |
+175,437
| New | +$23.7M |
|
|
BDSI
33
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $23.4M | 0.74% |
+6,184,243
| New | +$23.4M |
|
34
DexCom
DXCM
$30.9B
| $23.4M | 0.74% |
+348,000
| New | +$23.4M |
|
35
Rocket Pharmaceuticals
RCKT
$358M
| $23.4M | 0.74% |
1,677,367
-487,104
| -23% | -$6.8M |
|
36
Molina Healthcare
MOH
$9.6B
| $23.1M | 0.73% |
165,000
+16,567
| +11% | +$2.31M |
|
37
Sarepta Therapeutics
SRPT
$1.98B
| $23M | 0.73% |
235,000
+25,000
| +12% | +$2.45M |
|
38
Editas Medicine
EDIT
$225M
| $23M | 0.73% |
1,158,841
| – | – |
|
|
SWTX
39
DELISTED
SpringWorks Therapeutics
SWTX
| $21.3M | 0.68% |
788,243
| – | – |
|
|
DBVT
40
DBV Technologies
DBVT
$249M
| $20.4M | 0.65% |
520,969
+45,369
| +10% | +$1.78M |
|
41
Adverum Biotechnologies
ADVM
$68.2M
| $20.3M | 0.64% |
207,500
+186,366
| +882% | +$18.2M |
|
42
argenx
ARGX
$44.2B
| $20M | 0.63% |
151,779
-32,221
| -18% | -$4.24M |
|
|
MRTX
43
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $18.6M | 0.59% |
242,200
+68,200
| +39% | +$5.24M |
|
|
TPTX
44
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $18.5M | 0.59% |
413,321
+47,321
| +13% | +$2.11M |
|
45
Ardelyx
ARDX
$1.57B
| $17.5M | 0.56% |
3,083,000
-3,921,253
| -56% | -$22.3M |
|
|
TECX
46
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $17.5M | 0.56% |
93,740
-3,341
| -3% | -$624K |
|
47
Korro Bio
KRRO
$244M
| $16.8M | 0.53% |
18,914
-9,459
| -33% | -$8.42M |
|
|
MYOK
48
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $16.2M | 0.52% |
346,409
-442,591
| -56% | -$20.7M |
|
49
Glaukos
GKOS
$5.42B
| $16M | 0.51% |
+517,982
| New | +$16M |
|
50
Select Medical
SEM
$1.6B
| $15.9M | 0.51% |
1,972,928
+500,749
| +34% | +$4.05M |
|